182 related articles for article (PubMed ID: 19591217)
1. Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease.
Jeyakumar M; Lee JP; Sibson NR; Lowe JP; Stuckey DJ; Tester K; Fu G; Newlin R; Smith DA; Snyder EY; Platt FM
Stem Cells; 2009 Sep; 27(9):2362-70. PubMed ID: 19591217
[TBL] [Abstract][Full Text] [Related]
2. Improvement of motor and behavioral activity in Sandhoff mice transplanted with human CD34+ cells transduced with a HexA/HexB expressing lentiviral vector.
Beegle J; Hendrix K; Maciel H; Nolta JA; Anderson JS
J Gene Med; 2020 Sep; 22(9):e3205. PubMed ID: 32335981
[TBL] [Abstract][Full Text] [Related]
3. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.
Lee JP; Jeyakumar M; Gonzalez R; Takahashi H; Lee PJ; Baek RC; Clark D; Rose H; Fu G; Clarke J; McKercher S; Meerloo J; Muller FJ; Park KI; Butters TD; Dwek RA; Schwartz P; Tong G; Wenger D; Lipton SA; Seyfried TN; Platt FM; Snyder EY
Nat Med; 2007 Apr; 13(4):439-47. PubMed ID: 17351625
[TBL] [Abstract][Full Text] [Related]
4. Abnormal organization during neurodevelopment in a mouse model of Sandhoff disease.
Ogawa Y; Sasanuma Y; Shitara S; Koshizuka A; Okada R; Sakuraba H; Oishi K
Neurosci Res; 2020 Jun; 155():12-19. PubMed ID: 31340161
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice.
Arthur JR; Lee JP; Snyder EY; Seyfried TN
Neurochem Res; 2012 Jun; 37(6):1335-43. PubMed ID: 22367451
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
7. Abnormal differentiation of Sandhoff disease model mouse-derived multipotent stem cells toward a neural lineage.
Ogawa Y; Kaizu K; Yanagi Y; Takada S; Sakuraba H; Oishi K
PLoS One; 2017; 12(6):e0178978. PubMed ID: 28575132
[TBL] [Abstract][Full Text] [Related]
8. Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates.
Walia JS; Altaleb N; Bello A; Kruck C; LaFave MC; Varshney GK; Burgess SM; Chowdhury B; Hurlbut D; Hemming R; Kobinger GP; Triggs-Raine B
Mol Ther; 2015 Mar; 23(3):414-22. PubMed ID: 25515709
[TBL] [Abstract][Full Text] [Related]
9. Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease.
Yamaguchi A; Katsuyama K; Suzuki K; Kosaka K; Aoki I; Yamanaka S
J Mol Med (Berl); 2003 Mar; 81(3):185-93. PubMed ID: 12682727
[TBL] [Abstract][Full Text] [Related]
10. Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation.
Allende ML; Cook EK; Larman BC; Nugent A; Brady JM; Golebiowski D; Sena-Esteves M; Tifft CJ; Proia RL
J Lipid Res; 2018 Mar; 59(3):550-563. PubMed ID: 29358305
[TBL] [Abstract][Full Text] [Related]
11. In vivo and ex vivo MRI detection of localized and disseminated neural stem cell grafts in the mouse brain.
Magnitsky S; Watson DJ; Walton RM; Pickup S; Bulte JW; Wolfe JH; Poptani H
Neuroimage; 2005 Jul; 26(3):744-54. PubMed ID: 15955483
[TBL] [Abstract][Full Text] [Related]
12. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
Tsuji D
Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522
[TBL] [Abstract][Full Text] [Related]
13. Deletion of tumor necrosis factor-α ameliorates neurodegeneration in Sandhoff disease mice.
Abo-Ouf H; Hooper AW; White EJ; Janse van Rensburg HJ; Trigatti BL; Igdoura SA
Hum Mol Genet; 2013 Oct; 22(19):3960-75. PubMed ID: 23727835
[TBL] [Abstract][Full Text] [Related]
14. Characterization of inducible models of Tay-Sachs and related disease.
Sargeant TJ; Drage DJ; Wang S; Apostolakis AA; Cox TM; Cachón-González MB
PLoS Genet; 2012 Sep; 8(9):e1002943. PubMed ID: 23028353
[TBL] [Abstract][Full Text] [Related]
15. Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.
Wada R; Tifft CJ; Proia RL
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10954-9. PubMed ID: 11005868
[TBL] [Abstract][Full Text] [Related]
16. Homologous transplantation of neural stem cells to the injured spinal cord of mice.
Pallini R; Vitiani LR; Bez A; Casalbore P; Facchiano F; Di Giorgi Gerevini V; Falchetti ML; Fernandez E; Maira G; Peschle C; Parati E
Neurosurgery; 2005 Nov; 57(5):1014-25; discussion 1014-25. PubMed ID: 16284571
[TBL] [Abstract][Full Text] [Related]
17. Human neural stem cells overexpressing glial cell line-derived neurotrophic factor in experimental cerebral hemorrhage.
Lee HJ; Park IH; Kim HJ; Kim SU
Gene Ther; 2009 Sep; 16(9):1066-76. PubMed ID: 19554035
[TBL] [Abstract][Full Text] [Related]
18. AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system.
Rockwell HE; McCurdy VJ; Eaton SC; Wilson DU; Johnson AK; Randle AN; Bradbury AM; Gray-Edwards HL; Baker HJ; Hudson JA; Cox NR; Sena-Esteves M; Seyfried TN; Martin DR
ASN Neuro; 2015; 7(2):. PubMed ID: 25873306
[TBL] [Abstract][Full Text] [Related]
19. I. Abnormalities in cells of the testis, efferent ducts, and epididymis in juvenile and adult mice with beta-hexosaminidase A and B deficiency.
Adamali HI; Somani IH; Huang JQ; Mahuran D; Gravel RA; Trasler JM; Hermo L
J Androl; 1999; 20(6):779-802. PubMed ID: 10591618
[TBL] [Abstract][Full Text] [Related]
20. Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model.
Lee HJ; Lim IJ; Lee MC; Kim SU
J Neurosci Res; 2010 Nov; 88(15):3282-94. PubMed ID: 20818776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
